Assembly/AU/4(XI) Page 8 SUMMARY STATUS ON IMPLEMENTATION OF HIV AND AIDS STRATEGIES Due to political commitment and increased funding, a lot has been achieved although there are gaps that should be addressed. The following is a summary of the findings recorded for the period under review: i. The Global Fund to Fight AIDS, Tuberculosis and Malaria currently provides 20% of all funding for HIV/AIDS. The success rate of Round 7 proposals for HIV about 60% (10 out of 17). ii. Of the 35 countries that responded, 31 (90%), 28 (80%), and 21 (60%) reported of having policies or guidelines on ART, PMTCT, and HTC— respectively. iii. Almost two-thirds (63%) of the countries reported setting national targets for HTC, PMTCT, and ART. Over three quarters (77%), have set national PMTCT targets, while 70% (24 countries) have set for HTC and ART iv. Of the 35 countries that reported, 18 (46%) have a policy that allows lower level health workers—once trained—to provide second-level services, such as managing patients with HIV and ADIS v. Among 35 countries in the Africa region, one in every five facilities provide HTC services—ranging from less than 1% in Liberia to 100% in Botswana vi. In 2007, over 470,000 HIV positive pregnant women reportedly received ARVs for PMTCT purposes —over 50% increase from 2006 figure of slightly over 300,000. vii. In 2007, over 2.1 million people received ART in countries of this region. This represents a 60% increase in just one year—as 1.3 million people received ART in 2006. viii. Among the 35 countries that reported, 7 (20%) experienced stock outs of ARVs in part or all facilities that provide ART. ix. Of the 35 countries that submitted the Universal Access (UA) reporting form, 80% implement ANC surveillance by using the WHO-recommended HIV 2nd generation surveillance protocol. x. 77% of the countries have policies in place for HIV and AIDS and only 50% have developed HIV/AIDS guidelines in line with WHO recommendations. xi. Most countries have not developed or implemented Legislation on human rights and PLWA and TB; and to protect vulnerable groups against HIV/AIDS and TB.